(Q36775349)

English

Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

scientific article published on 19 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial (English)

1 reference

Europe PubMed Central

16 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

G Pfeiler

1

1 reference

Europe PubMed Central

16 August 2017

H Stöger

2

1 reference

Europe PubMed Central

16 August 2017

P Dubsky

3

1 reference

Europe PubMed Central

16 August 2017

B Mlineritsch

4

1 reference

Europe PubMed Central

16 August 2017

C Singer

5

1 reference

Europe PubMed Central

16 August 2017

M Balic

6

1 reference

Europe PubMed Central

16 August 2017

F Fitzal

7

1 reference

Europe PubMed Central

16 August 2017

M Moik

8

1 reference

Europe PubMed Central

16 August 2017

W Kwasny

9

1 reference

Europe PubMed Central

16 August 2017

U Selim

10

1 reference

Europe PubMed Central

16 August 2017

K Renner

11

1 reference

Europe PubMed Central

16 August 2017

F Ploner

12

1 reference

Europe PubMed Central

16 August 2017

G G Steger

13

1 reference

Europe PubMed Central

16 August 2017

M Seifert

14

1 reference

Europe PubMed Central

16 August 2017

F Hofbauer

15

1 reference

Europe PubMed Central

16 August 2017

P Sandbichler

16

1 reference

Europe PubMed Central

16 August 2017

H Samonigg

17

1 reference

Europe PubMed Central

16 August 2017

R Jakesz

18

1 reference

Europe PubMed Central

16 August 2017

R Greil

19

1 reference

Europe PubMed Central

16 August 2017

C Fesl

20

1 reference

Europe PubMed Central

16 August 2017

M Gnant

21

1 reference

Europe PubMed Central

16 August 2017

ABCSG

22

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

19 March 2013

1 reference

Europe PubMed Central

16 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

16 August 2017

108

1 reference

Europe PubMed Central

16 August 2017

7

1 reference

Europe PubMed Central

16 August 2017

1408-1414

1 reference

Europe PubMed Central

16 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.2013.114

0 references

Body-Mass Index and Mortality among 1.46 Million White Adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Prevalence and trends in obesity among US adults, 1999-2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Abdominal obesity and metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

29 September 2017

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

5 September 2018

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

5 September 2018

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

5 September 2018

Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

5 September 2018

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629426

5 September 2018

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen and estrogen metabolism: relationship to obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is obesity an independent prognosis factor in woman breast cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on prognosis after early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2013.114

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36775349&oldid=1962146436"